Bioo Scientific MaxDiscovery AST and LDH colour endpoint assay kits

Bioo Scientific’s MaxDiscovery Aspartate Transaminase (AST) and Lactate Dehydrogenase (LDH) colour endpoint assays use a proprietary technology for visible detection of in vivo toxicity using only 5 µL of serum from rodents or other mammals. These assays are powerful tools for the detection of drug-induced toxicity to the liver and heart and can be used for preclinical testing in the drug discovery process.

The assays employ simplified endpoint analysis to offer high sensitivity, low detection limits and the ability to use a visible plate reader.

The MaxDiscovery Aspartate Transaminase (AST) kit permits quantitative visible determination of AST in a convenient format. Unlike previous LDH tests, the MaxDiscovery LDH Color Endpoint Assay kit measures the direct chemical conversion of LDH and does not rely on coupled enzymatic amplification for high-precision, quantitative measurements. Each kit contains ready-to-use product standards for the development of standard curves and accurate calibration of the assay.